- Moderate-to-severe depression quadruples the death rate among heart failure patients.
- Patients who have heart failure and are also moderately or severely depressed are twice as likely to go the emergency room or require hospitalization.
- Heart failure patients who report feeling mildly depressed also had an increased risk of death.
“Depression is a key driver of healthcare use in heart failure,” said Alanna M. Chamberlain, Ph.D., M.P.H., the study’s lead author and assistant professor of epidemiology in the Department of Health Sciences Research at the Mayo Clinic in Rochester, Minn. “Treatment programs should be tailored to each patient’s needs with greater emphasis on managing depression either through medication or lifestyle interventions.”
In 2007-10, 402 heart failure patients (58 percent male, average age 73) in three Minnesota counties completed a nine-question survey. Based on the answers, 59 percent of patients were classified as having no depression, 26 percent had mild depression and 15 percent had moderate-to-severe depression. Researchers gathered information on the participants for about a year and a half.
Even those who reported mild depression had almost a 60 percent increased risk of death, but a much smaller increased risk of emergency room visits (35 percent) and hospitalizations (16 percent), researchers found.
Because the patients studied were mostly white and lived in southeastern Minnesota, the results may not apply to all heart failure patients throughout the United States, researchers said only a third of the patients with moderate-to-severe depression were taking antidepressant medication. Depression may be underdiagnosed in these patients; however, some may have been undergoing therapy that didn’t include prescription drugs, researchers said.
“We measured depression with a one-time questionnaire so we cannot account for changes in depression symptoms over time,” Chamberlain said. “Further research is warranted to develop more effective clinical approaches for management of depression in heart failure patients.”
Co-authors are: Amanda R. Moraska, B.A.; Nilay D. Shah, Ph.D.; Kristin S. Vickers, Ph.D.; Teresa A. Rummans, M.D.; Shannon M. Dunlay, M.D., M.Sc.; John A. Spertus, M.D., M.P.H; Susan A. Weston, M.S.; Sheila M. McNallan, M.P.H.; Margaret M. Redfield, M.D.; and Veronique L. Roger, M.D., M.P.H. Author disclosures are on the manuscript.
The National Heart, Lung, and Blood Institute and the National Institute on Aging funded the study.
For additional information on heart failure and depression, visit: http://newsroom.heart.org/news/depression-in-heart-failure-patients-233191.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
Additional resources, including multimedia, are available in the right column of this link: http://newsroom.heart.org/news/heart-failure-patients-with-depression-have-four-times-risk-of-death?preview=068e4bac4e7be77ac915c7ce6fbf8f76